AHR and breast carcinoma: The results of the study by Yamashita et al. (2022) indicate that the inhibition of cell proliferation, migration, and mammosphere formation by camalexin specifically depends on the activation of AhR in ER-negative, PgR-positive, and HER2-negative breast cancer cell lines, such as MCF-7 and T47D [74].